Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,216 | 53,814 | 108,970 | 35,944 | 24,442 |
| Marketable Securities | 267,864 | 328,628 | 274,729 | 136,653 | 136,686 |
| Receivables | 27,021 | 27,467 | 27,702 | 29,937 | 26,765 |
| Inventories | 39,112 | 33,602 | 30,311 | 31,278 | 37,476 |
| TOTAL | $365,835 | $450,991 | $447,964 | $243,089 | $235,444 |
| Non-Current Assets | |||||
| PPE Net | 105,947 | 103,239 | 102,571 | 101,016 | 100,388 |
| Investments And Advances | 80,807 | 0 | 0 | 0 | 0 |
| Intangibles | 52,956 | 50,943 | 48,829 | 46,737 | 44,670 |
| Other Non-Current Assets | 545 | 572 | 598 | 624 | 651 |
| TOTAL | $240,255 | $154,754 | $151,998 | $148,377 | $145,709 |
| Total Assets | $606,090 | $605,745 | $599,962 | $391,466 | $381,153 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,278 | 10,392 | 9,373 | 7,511 | 7,287 |
| Accrued Expenses | 39,701 | 46,755 | 34,900 | 36,666 | 31,077 |
| TOTAL | $52,337 | $57,510 | $45,648 | $44,838 | $146,831 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 520 | 595 | 822 |
| Other Non-Current Liabilities | 288,953 | 287,187 | 276,324 | 127,652 | 12,557 |
| TOTAL | $288,953 | $287,187 | $283,681 | $127,652 | $20,174 |
| Total Liabilities | $341,290 | $344,697 | $329,329 | $172,490 | $167,005 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,570 | 40,342 | 40,094 | 37,525 | 37,402 |
| Common Shares | 41 | 40 | 40 | 37 | 37 |
| Retained earnings | -393,731 | -386,134 | -366,391 | -346,238 | -342,266 |
| Other shareholders' equity | -67 | -64 | -82 | -30 | -28 |
| TOTAL | $264,800 | $261,048 | $270,633 | $218,976 | $214,148 |
| Total Liabilities And Equity | $606,090 | $605,745 | $599,962 | $391,466 | $381,153 |